BioCentury
ARTICLE | Company News

GenturaDx, Luminex deal

July 16, 2012 7:00 AM UTC

Luminex will acquire molecular diagnostics company GenturaDx for $50 million in cash and up to $3 million in development and regulatory milestones by Dec. 31, 2013, and $7 million in development and regulatory milestones by June 30, 2014, as well as undisclosed sales milestones. The deal gives Luminex access to GenturaDx's single-use cassette extraction, amplification and detection system, which Luminex plans to launch in 2014. Details were not disclosed. ...